UPPER NYACK, N.Y.--(BUSINESS WIRE)--The Global Healthy Living Foundation (GHLF) is excited to present innovative and transformative research at the American College of Rheumatology (ACR ...

If you live with psoriatic arthritis (PsA), you’re likely aware ... connected and what you can do to combat the symptoms. People living with PsA are more likely to experience depression and ...

Long COVID continues to leave millions grappling with persistent symptoms, challenging the path to recovery and highlighting ...

Hip replacement (also known as total hip replacement or total hip arthroplasty) is a surgical procedure that is performed to ...

HOUSE, PA — Johnson & Johnson (NYSE: JNJ) has announced encouraging results from its Phase 3 investigational study of ...

While potentially useful for treating severe knee OA, there is no strong evidence that gabapentin can provide relief from autoimmune forms of arthritis, such as rheumatoid arthritis and psoriatic ...

Highlights in psoriatic arthritis from ACR 2024 include results of methotrexate added to DMARD therapy, responses to bimekizumab, and improvements gained by upadacitinib after prior TNF inhibitor use.

Common types of arthritis include osteoarthritis (OA), rheumatoid arthritis (RA), and psoriatic arthritis (PsA). Each type develops differently, but all are painful and can lead to joint changes ...

Apremilast (APR) shows significant efficacy and safety over 48 weeks for the management of early oligoarticular psoriatic arthritis (PsA), according to study results presented at the American College ...

Researchers evaluated the efficacy and safety of ixekizumab over a 16-week period for the treatment of juvenile psoriatic arthritis or enthesitis-related arthritis.

Psoriatic arthritis treatments can vary depending on the range and severity of symptoms that you may experience. When people with psoriatic arthritis begin to experience moderate or severe symptoms ...